BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

Post time 2024-6-13 16:50:28

journal：Annals of the Rheumatic Diseases

Authors：Weijia Wang; Shanzhi He; Wenli Zhang; Hongyu Zhang; Vincent M DeStefano; Masayuki Wada; Kevin Pinz; Greg Deener; Darshi Shah; Nabil Hagag; Min Wang; Ming Hong; Ronghao Zeng; Ting Lan; Yu Ma; Fugui Li; Yingwen Liang; Zhencong Guo; Chanjuan Zou; Mingxia Wang; Ling Ding; Yupo Ma; Yong Yuan

Published date：--

DOI：10.1136/ard-2024-225785

PDF link：https://syndication.highwire.org ... 136/ard-2024-225785

Article link：http://dx.doi.org/10.1136/ard-2024-225785

Article Source：BMJ。

Remark：

Post time 2024-6-13 16:50:29

: This post has been completed
Completed attachments will be deleted within 24 hours.

[BMJ] BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[BMJ] BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[BMJ] BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial